Care Study John Draft
Introduction:
John is a retired man in his late 70s, and he has a medical history of type 2 diabetes for the last five years. He has started indicating symptoms of hyperglycaemia for the previous two years. His blood glucose level reached 118-127 mg/dl. He is obese and should lose weight.
Assessment:
Upon initial treatment, the patient is the critical stage of diabetes, and he requires a diabetes physician. He has been trying to lose weight but could not do so. The disease and the present situation of the patient require an assessment to plan for his treatment. The problems with the patient are mainly two. First, the assessment shows that he should reduce his sugar levels, and physical activity can help him a lot. Secondly, he requires an assistant for physical activity so that his diseases may come under control. Some medications have not proven suitable for him. For instance, he was started on glyburide 2.5 mg every morning, but it caused dizziness and sweating. He developed symptoms of fatigue and agitation (DiSogra and Meece, 2019). He has also been taking hypercholesterolemia, chromium picolinate, and Gymnema Sylvestre for the past few months. However, it has not benefited him positively. These assessment results suggested him to be under medical treatment from a caregiver at home.
Planning:
The examination of the patient was the first stage of planning. It included the pathophysiology of his medical condition and pharmacology of a specific medication. Pathophysiology indicates that he has 178 pounds of weight with body mass index is under 33 kg/m2. Its capillary glucose level in the morning stands at 166 mg/dl. The blood pressure is at 154/96 mmHg on the right arm while lying and 140/90 mmHg while sitting. Thus, he has type 2 diabetes at an uncontrolled level. Other diseases include obesity, hyperlipidemia, and hypertension. Low physical activity is also a problem as he is not losing weight despite any physical activity. The prescribed medicine for the patient is metformin 500 mg, and titration schedule to increase the dosage to 1000 mg two times a day. The selection of this medication was because of fewer side effects on obesity (Diabetes Prevention Program Research Group, 2015).
Implementation:
The implementation of the treatment for the patient consists of assistance for physical activity and reduced side effects towards obesity. Medicines for diabetes should cure the disease only, and it should not lead to the cause of obesity. Some other medications are also helpful in curing diabetes, but the chosen medication does not contribute to weight gain. Thiazolidinediones or pioglitazone, and sulfonylurea are some medications to deal with diabetes. But they cause weight gain. Therefore, these medications have not been implemented for the treatment (Ko, Kim, and Lee, 2017).
Evaluation:
The selection of medication may result in many benefits like it would cure the illness faced by the patient. It also affects his health positively because it has the least side effects. The recommended treatment is effective, and evidence supports it. The decision-making for the chosen treatment is the result of the assessment taken by the patient (Mundt et al., 2016).
Conclusion
This section concludes that the patient requires treatment of a high level of diabetes, and the chosen treatment is appropriate. I worked as a caregiver for the patient, and it helped him gain better health.
References
Diabetes Prevention Program Research Group (2015) ‘Long-term effects of lifestyle intervention or metformin on diabetes development and microvascular complications over 15-year follow-up: the Diabetes Prevention Program Outcomes Study’, The lancet Diabetes & endocrinology, vol. 3, no. 11, pp. 866-875.
DiSogra, R.M. and Meece, J. (2019) ‘Auditory and Vestibular Side Effects of FDA-Approved Drugs for Diabetes’, Seminars in hearing, vol. 40, no. 4, pp. 315-326.
Ko, K.D., Kim, K.K. and Lee, K.R. (2017) ‘Does Weight Gain Associated with Thiazolidinedione Use Negatively Affect Cardiometabolic Health?’, Journal of obesity & metabolic syndrome, vol. 26, no. 2, pp. 102-106.
Mundt, M.P., Agneessens, F., Tuan, W.-J., Zakletskaia, L.I., Kamnetz, S.A. and Gilchrist, V.J. (2016) ‘Primary care team communication networks, team climate, quality of care, and medical costs for patients with diabetes: a cross-sectional study’, International journal of nursing studies, vol. 58, pp. 1-11.
